口腔鳞状细胞癌免疫相关预后风险模型的构建与验证

doi:10.19439/j.sjos.2024.04.003

上海口腔医学 ›› 2024, Vol. 33 ›› Issue (4): 345-353.doi: 10.19439/j.sjos.2024.04.003

口腔鳞状细胞癌免疫相关预后风险模型的构建与验证

赵娇¹, 隋佰延², 刘昕^2,*, 阮敏^1,3,*

1.潍坊医学院口腔医学院,山东潍坊 261053;
2.上海交通大学医学院附属第九人民医院上海生物材料研究测试中心, 3.口腔颌面-头颈肿瘤科, 上海交通大学口腔医学院,国家口腔医学中心,国家口腔疾病临床医学研究中心, 上海市口腔医学重点实验室,上海市口腔医学研究所,上海 200011

收稿日期:2023-05-17 修回日期:2023-07-05 出版日期:2024-08-25 发布日期:2024-09-03
通讯作者: 刘昕,E-mail: Liuxin0556@163.com;阮敏,E-mail: doctorruanmin@sjtu.edu.cn。^*共同通信作者
作者简介:赵娇（1995-）,女,在读硕士研究生,E-mail: zj2812@126.com
基金资助:
国家自然科学基金（82072983）; 上海市科学技术委员会科研项目（21DZ2291700）; 上海交通大学医学院附属第九人民医院早期口腔癌的生物样本库（YBKA202203）

Construction and validation of an immune prognostic risk model in oral squamous cell carcinoma

ZHAO Jiao¹, SUI Bai-yan², LIU Xin², RUAN Min^1,3

1. School of Stomatology, Weifang Medical University. Weifang 261053, Shandong Province;
2. Department of Dental Materials, 3. Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Shanghai Research Institute of Stomatology. Shanghai 200011, China

Received:2023-05-17 Revised:2023-07-05 Online:2024-08-25 Published:2024-09-03

摘要/Abstract

摘要： 目的：分析口腔鳞癌（oral squamous cell carcinoma, OSCC）中差异表达的免疫相关核心基因,构建OSCC患者的免疫相关预后风险模型。方法：对癌症基因组图谱(the cancer genome atlas, TCGA) 数据库内的OSCC患者RNA测序数据进行加权基因共表达网络分析,识别免疫相关模块和关键基因。采用单因素Cox回归分析和生存分析,筛选与免疫预后相关的核心基因,构建OSCC的免疫相关预后风险模型;进一步采用Kaplan-Meier分析、受试者工作特征曲线和来自外部GSE41613数据集评估该预后风险模型的预测能力。应用实时荧光定量PCR（RT-qPCR）检测OSCC患者肿瘤组织样本中8个免疫预后核心基因的表达,计算风险评分,评估该评分与肿瘤浸润深度间的相关性。采用SPSS 21.0软件包对数据进行统计学分析。结果：成功构建基于8个免疫预后核心基因（CSF2RA、CLEC4C、COL5A3、CTSG、EDNRA、GPC4、GUCY1A2和ANGPT2）的口腔鳞癌预后风险模型。Kaplan-Meier分析、受试者工作特征曲线和外部GSE41613数据集验证显示,该模型具有良好的预后预测效能。基于该模型计算的OSCC患者的风险评分与肿瘤浸润深度呈正相关,表明该模型同时具有预测OSCC潜在风险的能力。结论：基于8个免疫预后核心基因构建的预后风险模型具有预测OSCC患者预后的能力,有望成为口腔鳞癌免疫防治的重要参考。

关键词: 口腔鳞状细胞癌, 加权基因共表达网络分析, 免疫预后相关基因, 预后风险模型

Abstract: PURPOSE: To analyze the immune-related core genes differentially expressed in oral squamous cell carcinoma(OSCC) and construct an immune-related prognostic risk model for OSCC patients. METHODS: Weighted gene co-expression network analysis of RNA sequencing data from OSCC patients in the Cancer Genome Atlas (TCGA) database was conducted to identify immune-related modules and core genes. Core genes associated with immune prognosis were screened using univariate Cox regression analysis and survival analysis to construct an immune-related prognostic risk model for OSCC. The prognostic risk model's predictive ability was evaluated using Kaplan-Meier analysis, receiver operating characteristic curves, and external datasets from GSE41613. The expression of 8 immune prognostic core genes in tumor samples from OSCC patients was detected by real-time quantitative PCR assay(RT-qPCR), and the correlation between risk score and depth of invasion was assessed by calculating risk scores for OSCC patients. Statistical analysis was performed with SPSS 21.0 software package. RESULTS: Prognostic risk model for OSCC was successfully constructed based on 8 immune prognostic core genes(CSF2RA, CLEC4C, COL5A3, CTSG, EDNRA, GPC4, GUCY1A2, ANGPT2). The prognostic risk model demonstrated perfect predictive value validated using Kaplan-Meier analysis, receiver operating characteristic curve, and the GSE41613 dataset. The risk scores of OSCC patients calculated based on this model were positively correlated with the depth of invasion, indicating that the model have the ability to predict the potential risk of OSCC. CONCLUSIONS: An OSCC prognostic risk model is constructed based on the signatures of 8 immune prognostic core genes, which may effectively predict the prognosis of OSCC patients, providing an important reference for immune prevention of OSCC.

Key words: Oral squamous cell carcinoma, Weighted gene co-expression network analysis, Immune prognostic genes, Prognostic risk model

中图分类号:

R739.8

赵娇, 隋佰延, 刘昕, 阮敏. 口腔鳞状细胞癌免疫相关预后风险模型的构建与验证[J]. 上海口腔医学, 2024, 33(4): 345-353.

ZHAO Jiao, SUI Bai-yan, LIU Xin, RUAN Min. Construction and validation of an immune prognostic risk model in oral squamous cell carcinoma[J]. Shanghai Journal of Stomatology, 2024, 33(4): 345-353.

参考文献

[1] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[2] Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[3] Gupta B, Johnson NW, Kumar N.Global epidemiology of head and neck cancers: a continuing challenge[J]. Oncology, 2016, 91(1): 13-23.
[4] Siegel RL, Miller KD, Fuchs HE, et al.Cancer statistics, 2021[J]. CA Cancer J Clin, 2021,71(1): 7-33.
[5] Joyce JA, Pollard JW.Microenvironmental regulation of metastasis[J]. Nat Rev Cancer, 2009, 9(4): 239-252.
[6] Geng SK, Fu YP, Fu SM, et al.A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients[J]. Front Immunol, 2022, 13: 927565.
[7] Wu J, Li L, Zhang HB, et al.A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma[J]. Oncogene, 2021, 40(26): 4413-4424.
[8] Zhang J, Ma C, Qin H, et al.Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics[J]. BMC Med Genomics, 2022, 15(1): 269-284.
[9] Lu W, Yin C, Zhang T, et al.An oxidative stress-related prognostic signature for indicating the immune status of oral squamous cell carcinoma and guiding clinical treatment[J]. Front Genet, 2022, 13: 977902.
[10] Szklarczyk D, Morris JH, Cook H, et al.The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible[J]. Nucleic Acids Res, 2017, 45(D1): D362-d368.
[11] Franz M, Lopes CT, Huck G, et al.Cytoscape.js: a graph theory library for visualisation and analysis[J]. Bioinformatics, 2016, 32(2): 309-311.
[12] Autenshlyus A, Arkhipov S, Mikhailova E, et al.The relationship between cytokine production, CSF2RA, and IL1R2 expression in mammary adenocarcinoma, tumor histopathological parameters, and lymph node metastasis[J]. Technol Cancer Res Treat, 2019, 18: 1533033819883626.
[13] Kunze K, Frank M, Bodner J, et al.Differentiation of primary and metastatic tumours in synchronous multifocal colonic and bronchopulmonary adenocarcinoma by targeted next-generation sequencing[J]. Histopathology, 2014, 64(7): 1041-1043.
[14] Zhao DR, Liu SZ, Sun LL, et al.Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma[J]. Virus Res, 2016, 220: 52-56.
[15] Muendlein A, Heinzle C, Brandtner EM, et al.Circulating glypican-4 is a predictor of 24-month overall survival in metastatic breast cancer[J]. Oncol Res Treat, 2023, 46(4): 151-156.
[16] Huang TY, Wu CC, Su WT.Biological and cytoprotective effect of Piper kadsura ohwi against hydrogen-peroxide-induced oxidative stress in human SW1353 cells[J]. Molecules, 2021, 26(20): 6287-6310.
[17] Wu F, Du YY, Hou XJ, et al.A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden[J]. Bmc Oral Health, 2022, 22(1): 152-166.
[18] Truby LK, Kwee LC, Agarwal R, et al.Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation[J]. J Heart Lung Transplant, 2021, 40(12): 1589-1598.
[19] Chen YS, Teng LC, Liu WH, et al.Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach[J]. Cancer Cell Int, 2016, 16: 16-24.
[20] Yang SF, Zou XM, Li JC, et al.Immunoregulation and clinical significance of neutrophils/NETs-ANGPT2 in tumor microenvironment of gastric cancer[J]. Front Immunol, 2022, 13: 1010434.
[21] Li C, Sun CJ, Fan JC, et al.Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma[J]. Med Oncol, 2013, 30(2): 571-581.
[22] Lee YJ, Jung ES, Choi J, et al.The EDN1/EDNRA/beta-arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylation[J]. Int J Oncol, 2023, 62(1): 13-27.
[23] D'Cruz AK, Dhar H, Vaish R, et al. Depth of invasion in early oral cancers- is it an independent prognostic factor?[J]. Eur J Surg Oncol, 2021, 47(8): 1940-1946.
[24] Wang F, Tan RK, Feng K, et al.Magnetic resonance imaging-based radiomics features associated with depth of invasion predicted lymph node metastasis and prognosis in tongue cancer[J]. J Magn Reson Imaging, 2022, 56(1): 196-209.
[25] Faisal M, Abu Bakar M, Sarwar A, et al.Depth of invasion (DOI) as a predictor of cervical nodal metastasis and local recurrence in early stage squamous cell carcinoma of oral tongue (ESSCOT)[J]. PLoS One, 2018, 13(8): e0202632.

口腔鳞状细胞癌免疫相关预后风险模型的构建与验证

Construction and validation of an immune prognostic risk model in oral squamous cell carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘文静, 李梦琦, 崔祥, 汪俊兰. circ_0000326靶向miR-567对口腔鳞状细胞癌HSC3细胞增殖、侵袭及迁移的调控效应[J]. 上海口腔医学, 2023, 32(6): 590-596.
[2]	陈兴金, 范然怡, 陶识丞, 薛睿, 文旭涛, 麦华明. 颈淋巴清扫术保留胸锁乳突肌与否对晚期口腔鳞癌预后的影响[J]. 上海口腔医学, 2023, 32(6): 609-614.
[3]	叶婷婷, 陈蔚华, 裴婧, 贾云香, 吴海莹. NEK2与EMT相关分子在口腔鳞状细胞癌中的表达及临床意义[J]. 上海口腔医学, 2023, 32(6): 640-644.
[4]	陈娟, 曹若妍, 刘洋, 洪鹏宇, 唐瞻贵. TNFAIP6在口腔疣状癌与口腔鳞状细胞癌中的表达及其与临床病理的关系[J]. 上海口腔医学, 2022, 31(2): 167-172.
[5]	靳能皓, 南欣荣, 闫星泉. BTG1在78例口腔鳞癌中的表达及临床意义[J]. 上海口腔医学, 2021, 30(2): 140-144.
[6]	王科, 彭国光, 谭玉莲, 何善志, 罗翠芬. miR-99a对口腔鳞癌增殖能力的影响[J]. 上海口腔医学, 2021, 30(1): 44-49.
[7]	黄丹妮, 陈文鑫, 熊浩峰, 胡鑫, 毛婷, 苏彤. 口腔鳞状细胞癌患者术后服用二甲双胍对预后的影响[J]. 上海口腔医学, 2021, 30(1): 61-65.
[8]	郑晶, 李天客, 包阳, 张素欣. Spindly和Bub3在口腔鳞状细胞癌中的表达及意义[J]. 上海口腔医学, 2020, 29(5): 528-532.
[9]	达雨, 杨震, 夏苗苗, 王梦佳. Ki-67、PI3K、Beclin1在口腔鳞癌组织中的表达及意义[J]. 上海口腔医学, 2020, 29(1): 75-79.
[10]	王培, 汤春波, 李斌, 傅宗云. LncTUG1通过靶向miR-212-3p对口腔鳞状细胞癌细胞NK细胞杀伤敏感性的影响[J]. 上海口腔医学, 2019, 28(6): 567-571.
[11]	杨宗澄, 黄海燕, 徐欣. 长链非编码RNA PCAT-1在口腔鳞状细胞癌中的表达及临床意义[J]. 上海口腔医学, 2019, 28(1): 67-70.
[12]	涂敏松, 李逸松, 张雄. YAP、TAZ蛋白在口腔鳞状细胞癌中的表达及意义[J]. 上海口腔医学, 2018, 27(4): 415-418.
[13]	李少明, 高岭, 任文豪, 薛令法, 许尧祥, 岳金, 郅克谦. 功能性与根治性颈淋巴清扫术在早期口腔鳞状细胞癌治疗中的疗效比较[J]. 上海口腔医学, 2017, 26(3): 305-308.
[14]	吴宁, 陆瑛, 梁继宗. Survivin和hsa-miR-542-3p在口腔鳞状细胞癌中的表达和相关性分析[J]. 上海口腔医学, 2016, 25(6): 720-724.
[15]	蒋丽兰, 赵娅军, 李勇. TGF-βRⅡ和NF-κB在口腔鳞状细胞癌的表达及临床意义[J]. 上海口腔医学, 2016, 25(6): 729-733.